5-Bromopyridine-2-carboxylic acid → HCID 71252484, compound
Reaction equation
[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[CH:11]1([C:14]2[C:15]([N:23]3[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]3)=[N:16][CH:17]=[C:18]([CH:20]3[CH2:22][CH2:21]3)[CH:19]=2)[CH2:13][CH2:12]1>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([N:26]2[CH2:27][CH2:28][N:23]([C:15]3[C:14]([CH:11]4[CH2:12][CH2:13]4)=[CH:19][C:18]([CH:20]4[CH2:22][CH2:21]4)=[CH:17][N:16]=3)[CH2:24][CH2:25]2)=[O:10])=[N:6][CH:7]=1Participants
3
Procedure
Using 5-bromo-2-picolinic acid (378 mg) and 1-(3,5-dicyclopropylpyridin-2-yl)piperazine (500 mg) described in Preparation Example 88 and by the reaction and treatment in the same manner as in Preparation Example 109, the title compound (798 mg) was obtained.
Workup
- customdescribed in Preparation Example 88 and by the reaction and treatment in the same manner as in Preparation Example 109
Sources & evidence
- ORD record
- ord-ae3bf125d68245c085ae329e4b736617
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…